Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junjun Ma

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
International Journal of Biological Sciences|May 17, 2021
NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activityBatuer Aikemu, Yanfei Shao, Guang Yang, et al.
International Journal of Biological Sciences|May 10, 2024
Cancer-derived exosomal lncRNA SNHG3 promotes the metastasis of colorectal cancer through hnRNPC-mediating RNA stability of β-cateninLing Huang, Guang Yang, Yanfei Shao, et al.
Acta Biochimica Et Biophysica Sinica|September 16, 2022
ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancerHi-Ju Hong, Yanfei Shao, Sen Zhang, et al.
Medical Oncology (Northwood, London, England)|November 11, 2015
PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganizationPuxiongzhi Wang, Jingkun Zhao, Xiao Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2026
Oncolytic Probiotics with Molecular Pili for Solid Tumor TherapyHaodong Ge, Chengsheng Ding, Xiao Yang, et al.
NPJ Precision Oncology|December 17, 2025
Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1Chaozhao Chen, Yanfei Shao, Xiaodong Fan, et al.
Genomics|March 6, 2024
Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancerYanfei Shao, Galiya Yesseyeva, Yihao Zhi, et al.
Journal of Advanced Research|August 11, 2024
NDRG1 enhances the sensitivity to Cetuximab by promoting Stat1 ubiquitylation in colorectal cancerGuang Yang, Chengsheng Ding, Xiao Yang, et al.
Surgical Endoscopy|November 3, 2018
Completely medial access by page-turning approach for laparoscopic right hemi-colectomy: 6-year-experience in single centerZirui He, Sen Zhang, Pei Xue, et al.
Cell Death & Disease|May 6, 2026
Six1 haploinsufficiency is associated with activation of NF-κB and TNF-related transcriptional signatures in aging miceTianxu Guo, Han Liu, Junjun Ma, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
International Journal of Biological Sciences|May 17, 2021
NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activityBatuer Aikemu, Yanfei Shao, Guang Yang, et al.
International Journal of Biological Sciences|May 10, 2024
Cancer-derived exosomal lncRNA SNHG3 promotes the metastasis of colorectal cancer through hnRNPC-mediating RNA stability of β-cateninLing Huang, Guang Yang, Yanfei Shao, et al.
Acta Biochimica Et Biophysica Sinica|September 16, 2022
ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancerHi-Ju Hong, Yanfei Shao, Sen Zhang, et al.
Medical Oncology (Northwood, London, England)|November 11, 2015
PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganizationPuxiongzhi Wang, Jingkun Zhao, Xiao Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2026
Oncolytic Probiotics with Molecular Pili for Solid Tumor TherapyHaodong Ge, Chengsheng Ding, Xiao Yang, et al.
NPJ Precision Oncology|December 17, 2025
Development and validation of a CAF-related signature for prognosis and therapy response in colorectal cancer: new insights on HSPB1Chaozhao Chen, Yanfei Shao, Xiaodong Fan, et al.
Genomics|March 6, 2024
Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancerYanfei Shao, Galiya Yesseyeva, Yihao Zhi, et al.
Journal of Advanced Research|August 11, 2024
NDRG1 enhances the sensitivity to Cetuximab by promoting Stat1 ubiquitylation in colorectal cancerGuang Yang, Chengsheng Ding, Xiao Yang, et al.
Surgical Endoscopy|November 3, 2018
Completely medial access by page-turning approach for laparoscopic right hemi-colectomy: 6-year-experience in single centerZirui He, Sen Zhang, Pei Xue, et al.
Cell Death & Disease|May 6, 2026
Six1 haploinsufficiency is associated with activation of NF-κB and TNF-related transcriptional signatures in aging miceTianxu Guo, Han Liu, Junjun Ma, et al.
Pageof 12